CSFS.L $6.89 -2.993%
MMXM3.SA $14.00 0%
HPP $4.35 -5.4348%
BEC.SI $1.65 0%
1621.HK $0.09 -1.0753%
SNA $254.34 -0.6601%
ABGI $10.19 0%
XOS $0.49 -3.4409%
PNS.L $300.00 0%
FLUX $3.58 -10.5%
2333.HK $9.80 -3.1621%
AWF $9.64 -0.8035%
SCAQ $10.25 0%
REAL $1.11 -8.5868%
0517.HK $2.63 -1.4981%
1851.HK $0.83 -12.6316%
LNT $54.83 0.4213%
8370.HK $0.07 -7.04225%
NFC.L $799.00 0%
SURF $0.61 -0.2787%
LOGN3.SA $46.56 0.5398%
BLIN $0.95 0%
VGSH $58.52 -0.1621%
ITM.L $75.22 -0.2916%
YANG $11.03 8.2522%
WDI $13.27 -1.1177%
VIVA3.SA $22.69 0.3095%
ADRD $22.23 0%
SPFF $8.64 -0.346%
0HC2.L $51.12 11.5305%
VDTA.L $25.37 -0.2653%
WSP.L $630.00 0%
LG9.SI $14.65 0.0683%
COHN $6.98 -0.1416%
SHQA $10.02 0%
RCOR $3.20 0%
TGI $10.11 -1.1253%
6818.HK $2.55 -1.9231%
BMKS3.SA $328.04 -4.9159%
MFX.L $25.90 3.6%
IDEA.L $349.00 0%
BCDAW $0.80 4.0649%
AAP $121.86 -1.8644%
0IHP.L $107.22 -0.4549%
TFII $107.29 1.0359%
APOG $38.41 0.5761%
RZA $24.98 0%
ALK.L $215.00 -8.5106%
WMC.CN $0.06 0%
MXASX $12.33 0%
ITCI $64.40 0.0466%
ROSE $10.52 -0.473%
QFIN $17.18 -2.1083%
MMAC $27.77 0%
CRDL.L $6.25 0%
FDBC $38.75 -1.7993%
PFE $37.29 -0.785%
ITT $80.83 -1.0285%
BELFA $44.42 -0.6264%
0277.HK $3.85 0.522466%
GUS.L $71.00 0.7092%
SPEU $38.94 -0.4519%
UUP $28.09 0.6017%
0144.HK $12.18 -1.9324%
INS $40.15 0%
0I4A.L $11.23 -1.1512%
BHR-PD $22.30 -1.9776%
ATQT.L $30.00 0%
SANBU $10.24 0%
PBPB $8.79 -0.5656%
AYLA $0.53 0%
INPP.L $144.00 -0.277%
VHNA $10.57 0.6667%
CFFEW $0.04 0%
BSL.SI $1.42 0%
0QLD.L $189.72 0.1155%
1921.HK $2.45 -0.8097%
ALTN.L $134.00 1.5152%
SHCA $10.06 0%
MNDY $129.83 -2.3908%
BNIX $10.45 0.0958%
0HLQ.L $40.00 -1.6476%
MVR2.L $100.00 -9.09091%
TAM.L $460.00 -1.0753%
PTRA $1.32 -6.383%
WCBR $17.58 -1.7548%
ENT.L $1 466.00 -0.509%
RISN $22.62 -0.1844%
0VL8.L $81.96 -2.4944%
HMG $22.80 0%
SYKE $54.00 0%
SANM $50.08 -6.4799%
GABC $26.21 -0.84%
EDSA $0.91 -3.5023%
FXZ $60.06 -0.2822%
8426.HK $0.16 -1.8987%
FINM $10.14 0%
NWSA $17.86 6.6607%
1268.HK $11.82 -3.4314%
ALC.MC $3.04 -3.7975%
Eng
Логотип
Eng
Лого

Millendo Therapeutics, Inc. MLND

$1.06

На 18:01, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    11148126.00000000

  • week52high

    41.55

  • week52low

    1.06

  • Revenue

    0

  • P/E TTM

    0

  • Beta

    0.47627600

  • EPS

    0.00000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    07 мая 2023 г. в 02:55

Описание компании

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.
Grading company New grade Previous grade Recommendation date
SVB Leerink Market Perform Outperform 06 янв 2021 г.
Ladenburg Thalmann Neutral Buy 06 янв 2021 г.
Citigroup Buy Buy 29 мая 2020 г.
Oppenheimer Perform Outperform 07 апр 2020 г.
Citigroup Buy Buy 25 мар 2020 г.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек

Insider Summary

Reporting Name Acquistion/Disposition Owned Transacted Transaction Date
Trojanowski Justin A 2500 2500 03 окт 2022 г.
Brady Stephen R A 173533 173533 21 июн 2022 г.
Dubensky Thomas W. A 87801 87801 21 июн 2022 г.
Whiting Samuel A 55680 55680 21 июн 2022 г.
Maestas Nicholas A 51270 51270 21 июн 2022 г.
Lorenzo Pierre A 8477 8477 21 июн 2022 г.
RAAB MICHAEL A 3500 3500 17 июн 2022 г.
Simantov Ronit A 3500 3500 17 июн 2022 г.
Woiwode Thomas A 3500 3500 17 июн 2022 г.
NICHOL GEOFFREY A 3500 3500 17 июн 2022 г.